Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.

CA19-9, a serum marker for pancreatic cancer, gives false-negative results in patients who are negative for the Lewis blood group phenotype. To determine whether other markers may compensate for this drawback, serum levels of CA50, Span-1, sialyl SSEA-1 and Dupan-2 were assayed and compared with tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawa, S., Oguchi, H., Kobayashi, T., Tokoo, M., Furuta, S., Kanai, M., Homma, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977472/
https://www.ncbi.nlm.nih.gov/pubmed/1931612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977472/
https://www.ncbi.nlm.nih.gov/pubmed/1931612

Ejemplares similares